Myriad signs five partnerships to study MRD testing in breast cancer

Myriad signs five partnerships to study MRD testing in breast cancer

Source: 
Clinical Trials Arena
snippet: 

The company plans to study the application of molecular residual disease (MRD) testing in breast cancer management using its Precise MRD test.